New drug shows promise in controlling rare blood clot disease
NCT ID NCT04683003
First seen Apr 07, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study looks at the long-term safety of a medicine called TAK-755 for people with a rare inherited condition that causes dangerous blood clots and bleeding. Participants receive the drug regularly to prevent flare-ups or as needed to treat them. The goal is to see if long-term use is safe and helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AKH - Medizinische Universität Wien
Vienna, 1090, Austria
-
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII)
Bergamo, Hubei, 24127, Italy
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100045, China
-
CHU Saint Etienne - Hôpital Nord
Saint-Priest-en-Jarez Cedex, Pays de la Loire Region, 42270, France
-
Childrens Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
Complejo Hospitalario Universitario A Coruña
A Coruña, La Coruña, 15006, Spain
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
Hospital de Cruces
Barakaldo, Vizcaya, 48903, Spain
-
Hyogo College of Medicine Hospital
Nishinomiya, Hyōgo, 663-8501, Japan
-
Hôpital Necker - Enfants Malades
Paris, Paris, 75015, France
-
Hôpital Robert Debré- Paris
Paris, 75935, France
-
Hôpital Saint-Antoine
Paris, 75012, France
-
Inselspital -Universitaetsspital Bern
Bern, 3010, Switzerland
-
Institute of Hematology and Hospital of Blood Disease
Tianjin, Tianjin Municipality, 300021, China
-
Instytut Hematologii i Transfuzjologii
Warsaw, 02-776, Poland
-
Kyushu University Hospital
Fukuoka, Fukuoka, 812-8582, Japan
-
Medical Hospital,Tokyo Medical and Dental University
Bunkyo City, Tokyo, 113-8519, Japan
-
Mid Ohio Heart Clinic Inc
Dublin, Ohio, 43017, United States
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
-
Roswell Park Comprehensive Cancer Center
Buffalo, New York, 14203, United States
-
Samodzielny Publiczny Dzieciecy Szpital Kliniczny
Warsaw, 02-091, Poland
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsushe, 215006, China
-
Tongji Hospital Affiliated to Tongji Medicine University
Wuhan, Hubei, 430030, China
-
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
-
Universitaetsklinikum Jena, Klinik fuerKinder-und Jugendmedizin
Jena, 07747, Germany
-
University College London Hospitals
London, Greater London, NW12PG, United Kingdom
-
University of Oklahoma
Oklahoma City, Oklahoma, 73104, United States
Conditions
Explore the condition pages connected to this study.